Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Res. 2009 Aug 25;69(17):6848–6856. doi: 10.1158/0008-5472.CAN-09-0786

Table 3.

Results for novel, sequencing-discovered genetic variants in the CHRNA5-CHRNA3 intergenic region

Novel variant rs number (if available) Position (bp) Minor allele Major allele COGEND EA original (N = 1591)
MAF p-value Odds ratio (95% confidence interval) Maximum r2 with previously genotyped SNPs
GSC3_2 76671157 TAAG DEL 0.0100 0.6773 1.16 (0.57–2.36) <0.2
GSC3_4 76671923 A T 0.0028 0.351 0.51 (0.13–2.09) 0.46
GSC3_15 rs62010327 76679839 A G 0.3666 0.8474 1.02 (0.87–1.18) 0.94
GSC3_16 76679938 DEL TACTC 0.0493 0.03726 0.71 (0.51 –0.98) 0.95
GSC3_17 rs55958820 76681412 T G 0.0098 0.1722 1.70 (0.79–3.61) <0.2
GSC3_18 rs57708953 76683263 T C 0.0039 0.6057 0.74 (0.23–2.36) 0.35
GSC3_20 76684921 T DEL 0.3719 0.9045 1.01 (0.87–1.17) 0.97
GSC3_26 76693692 G A 0.0648 0.006386 0.67 (0.500.89) 0.25
GSC3_27 76694121 T G 0.0060 0.7098 1.19 (0.48–2.97) <0.2
GSC3_28 76695823 T C 0.0063 0.6532 0.81 (0.33– 2.00) <0.2
GSC3_29 76696413 G C 0.0028 0.3521 0.51 (0.13–2.09) 0.46
1

Logistic regression, additive model